Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003080150 | SCV003480885 | likely benign | not provided | 2024-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004073169 | SCV003751693 | uncertain significance | not specified | 2022-12-05 | criteria provided, single submitter | clinical testing | The c.6022C>T (p.R2008C) alteration is located in exon 47 (coding exon 47) of the FBN3 gene. This alteration results from a C to T substitution at nucleotide position 6022, causing the arginine (R) at amino acid position 2008 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |